NOVEL SUBSTITUTED 7-DEAZAPURINE RIBONUCLEOSIDES FOR THERAPEUTIC USES

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F17%3A73591417" target="_blank" >RIV/61989592:15110/17:73591417 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20160609&CC=US&NR=2016159844A1&KC=A1" target="_blank" >https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20160609&CC=US&NR=2016159844A1&KC=A1</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
NOVEL SUBSTITUTED 7-DEAZAPURINE RIBONUCLEOSIDES FOR THERAPEUTIC USES
Original language description
Compounds of Formula I and a pharmaceutically acceptable salt thereof, an optical isomer thereof, or a mixture of optical isomers thereof, as well as compositions which include such compounds and therapeutic methods that utilize such compounds and/or compositions.
Czech name
—
Czech description
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Patent/design ID
US 9586986 B2
Publisher
US001 -
Publisher name
United States Patent and Trademark Office (USPTO)
Place of publication
Alexandria
Publication country
US - UNITED STATES
Date of acceptance
Mar 7, 2017
Owner name
Institute of Organic Chemistry and Biochemistry ASCR, v.v.i.; Palacky University in Olomouc
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
P - Využití výsledku jiným subjektem je v některých případech možné bez nabytí licence

Similar results(10)